Samuel Agresta Foghorn Therapeutics Inc. (FHTX) insider trading activity

FHTX Quotes by TradingView

Samuel Agresta is Chief Medical Officer of Foghorn Therapeutics Inc.. Currently has a direct ownership of 0 shares of FHTX, which is worth approximately $0. The most recent transaction as insider was on Aug 16, 2023, when has been sold 311,297 shares (Common Stock) at a price of $8.25 per share, resulting in proceeds of $2,568,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Samuel Agresta Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 16 2023
SELL
Open market or private sale
$2,568,200 $8.25 p/Share
311,297 Reduced 100.0%
0 Common Stock
Aug 16 2023
BUY
Exercise of conversion of derivative security
$1,158,024 $3.72 p/Share
311,297 Added 50.0%
311,297 Common Stock

Also insider at

INFI
INFINITY PHARMACEUTICALS, INC. Healthcare
RPHM
Reneo Pharmaceuticals, Inc. Healthcare
Chief Medical Officer
SA

Samuel Agresta

Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on FHTX

Follow Foghorn Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FHTX shares.

Notify only if

Insider Trading

Get notified when an Foghorn Therapeutics Inc. insider buys or sells FHTX shares.

Notify only if

News

Receive news related to Foghorn Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on FHTX